US reclassifies some marijuana products as less dangerous drug
Summary
The U.S. government has moved certain medical marijuana products from the most restricted drug category to a less strict one, allowing more research on their safety and benefits. This change does not legalize marijuana federally but reflects growing acceptance and relaxed rules in many states.Key Facts
- The Department of Justice reclassified some medical marijuana from Schedule I (most restricted) to Schedule III (less restricted).
- Schedule III drugs are seen as having a moderate to low risk of addiction.
- The change aims to improve research on marijuana’s safety and effectiveness.
- This action does not legalize recreational or medical marijuana under federal law.
- President Donald Trump signed an executive order in December 2024 to ease marijuana restrictions.
- Marijuana is legal in some form in 40 U.S. states.
- About 20% of Americans reported using marijuana in the past year, according to the CDC.
- A 2024 Pew poll showed 57% of U.S. adults support full legalization for recreational and medical use.
- The legal cannabis market is expected to reach $47 billion in sales by 2026.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.